The only manufacturer of smallpox vaccine has submitted clinical data and plans to expand the scope of vaccination.
Bavarian Nordic announced that it has submitted clinical data to the European Medicines Agency to seek an expansion of the indication for its Imvanex vaccine to adolescents aged 12-17. Yesterday, Sweden, the neighboring country of Denmark, reported the first confirmed case of monkeypox, which is also the first case confirmed outside the African continent since this epidemic outbreak.
Express News | Ibio Expands Executive Leadership Team With Appointment of Kristi Sarno as Senior Vice President of Business Development
IBio Price Target Announced at $3.60/Share by Brookline Capital
IBio Initiated at Buy by Brookline Capital
Brookline Capital Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $3.6
IBio Files $150M Mixed Shelf Offering
Express News | Ibio Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing
Express News | IBio Receives Notice of Allowance for US Patent Application 17/821,295 Titled "Anti-CD-25 Antibody for the Treatment of Cancer"
IBio Is Maintained at Buy by Chardan Capital
Chardan Capital Maintains Buy on IBio, Maintains $5 Price Target
Express News | Ibio Closes Sale of Manufacturing Facility in Texas
IBio Initiated at Buy by Chardan Capital
IBio Analyst Ratings
Express News | Ibio Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $5
Chardan Research Starts IBio With Buy Rating, $5 Price Target
Express News | Ibio Inc - Purchase and Sale Agreement Provides That Property Will Be Sold to Board of Regents for a Purchase Price of $8.5 Mln
Express News | Ibio Inc - Ibio CDMO LLC Entered Into Purchase, Sale Agreement, Dated as of May 17, With Board of Regents of Texas a&M University System
IBio Reports Q3 Results
iBio Inc | 10-Q: Q3 2024 Earnings Report
Express News | IBio Q3 EPS $(0.71) Up From $(9.53) YoY
No Data